RT Journal Article SR Electronic T1 RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.04.18.24302391 DO 10.1101/2024.04.18.24302391 A1 Potron, Anaïs A1 Daniel, Marion A1 Bay, Mila A1 Choulet, Pauline A1 Garrigos, Thomas A1 Sababadichetty, Loïk A1 Belmonte, Olivier A1 Fournier, Damien A1 Jeannot, Katy A1 Miltgen, Guillaume YR 2024 UL http://medrxiv.org/content/early/2024/04/19/2024.04.18.24302391.abstract AB The immunochromatographic assay RESIST ACINETO (Coris BioConcept) was evaluated on a collection of 121 Acinetobacter spp. clinical isolates, including 104 carbapenemase producers. The strains producing carbapenemases OXA-23, -40, -58, or/and NDM were accurately detected from bacterial cultures and directly from blood cultures, with the exception of an OXA-23/NDM-1-positive A. radioresistens isolate (only detected through standard culture). The performance of the RESIST ACINETO test was excellent (sensitivity 99%, specificity 100%) on this collection of isolates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by the French Ministry of Health via Sante Publique France, and the ERDF European program (RESISTO-RUN project, 20201126-0022906).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite d Ethique de Recherche en Maladies Infectieuses et Tropicales. Number IRB00011642I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.